Expert Leslie Randall, MD, discusses the case of a 71-year-old woman who is diagnosed with ovarian cancer. Dr. Randall reviews data with PARP inhibitors and rationale for use of maintenance therapy in patients with platinum-sensitive disease.
A 71-Year-Old Woman With Ovarian Cancer
A broad look at maintenance therapy selection and its use in ovarian cancer to improve patient outcomes.
Shared insight on the selection of PARP inhibitors for maintenance therapy in ovarian cancer with deference to patient and disease factors.
Focused discussion on the safety profiles of PARP inhibitors in ovarian cancer and how these can be mitigated with proper dose management.
Leslie Randall, MD, considers the possibility of relapse in ovarian cancer and reviews treatment options available at recurrence.
Closing out her discussion on ovarian cancer, Leslie Randall, MD, shares closing advice for community physicians on optimal treatment strategies.